PEI SHAN TAN: Open Payments
NPI 1932837168 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 27 payments from 10 companies in 2025. Trend: 2023 $186 · 2024 $157 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $380 |
| Madrigal Pharmaceuticals | 8 | $224 |
| Exact Sciences Corporation | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| RedHill Biopharma Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
Products named: REZDIFFRA, Wegovy, Ozempic, Cologuard Collection Kit, INVEGA SUSTENNA, BEYFORTUS, MOUNJARO, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
